Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in Patients with moderate-to-severe genital psoriasis

Authors
Category Primary study
ConferenceJDDG - Journal of the German Society of Dermatology
Year 2018
This article has no abstract
Epistemonikos ID: edb4c29927f2910b97a073b26587b6c1dce1a455
First added on: Apr 29, 2026